M. Bednarczyk

Toward anticancer immunotherapeutics: well-defined polymer-antibody conjugates for selective dendritic cell targeting.

R. Zentel, M. Bros, K. Koynov, 2014, Macromolecular bioscience.

Complement-Opsonized Nano-Carriers Are Bound by Dendritic Cells (DC) via Complement Receptor (CR)3, and by B Cell Subpopulations via CR-1/2, and Affect the Activation of DC and B-1 Cells

M. Bros, M. Roskamp, S. Grabbe, 2021, International journal of molecular sciences.

Neutrophil-Specific Knockdown of β2 Integrins Impairs Antifungal Effector Functions and Aggravates the Course of Invasive Pulmonal Aspergillosis

M. Gunzer, M. Bros, S. Grabbe, 2022, Frontiers in Immunology.

β2 Integrins on Dendritic Cells Modulate Cytokine Signaling and Inflammation-Associated Gene Expression, and Are Required for Induction of Autoimmune Encephalomyelitis

A. Waisman, M. Bros, K. Karram, 2022, Cells.

Impaired Treg-DC interactions contribute to autoimmunity in leukocyte adhesion deficiency type 1

A. Enk, A. Waisman, M. Bros, 2022, JCI insight.

β2 Integrins—Multi-Functional Leukocyte Receptors in Health and Disease

M. Bros, S. Grabbe, H. Stege, 2020, International journal of molecular sciences.